Diffuse Large B-Cell Lymphoma

Co-Founder and CEO to Attend JPMorgan Healthcare Conference

Diffuse Large B-Cell Lymphoma

Massive Bio’s Co-Founder and CEO, Selin Kurnaz, will be meeting with investors and partners at the JPMorgan Healthcare Conference from January 13-16, 2020 in San Francisco. This is the largest annual healthcare investment symposium with over 9,000 attendees who encompass the global healthcare investment landscape. To learn more about this conference please visit here.

Anyone interested in scheduling a meeting with Selin Kurnaz on these dates please contact us at [email protected].

[EN] Cancer Types
Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday

By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

Massive Bio’s Co-Founder and CEO, Selin Kurnaz, will be meeting with investors and partners at the JPMorgan Healthcare Conference from January 13-16, 2020 in San Francisco. This is the largest annual healthcare investment symposium with over 9,000 attendees who encompass the global healthcare investment landscape. To learn more about this conference please visit here.

Anyone interested in scheduling a meeting with Selin Kurnaz on these dates please contact us at [email protected].

[EN] Cancer Types
Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday

By filling out this form, you're consenting only to release your medical records. You're not agreeing to participate in clinical trials yet.

Massive Bio has onboarded over 160,000+ cancer patients to find their clinical trial

Most Recent Article

Start Your Journey